Viewing Study NCT05742750


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 3:16 PM
Study NCT ID: NCT05742750
Status: UNKNOWN
Last Update Posted: 2023-02-24
First Post: 2023-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module